Tags
Language
Tags
June 2025
Su Mo Tu We Th Fr Sa
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 1 2 3 4 5
    Attention❗ To save your time, in order to download anything on this site, you must be registered 👉 HERE. If you do not have a registration yet, it is better to do it right away. ✌

    https://sophisticatedspectra.com/article/drosia-serenity-a-modern-oasis-in-the-heart-of-larnaca.2521391.html

    DROSIA SERENITY
    A Premium Residential Project in the Heart of Drosia, Larnaca

    ONLY TWO FLATS REMAIN!

    Modern and impressive architectural design with high-quality finishes Spacious 2-bedroom apartments with two verandas and smart layouts Penthouse units with private rooftop gardens of up to 63 m² Private covered parking for each apartment Exceptionally quiet location just 5–8 minutes from the marina, Finikoudes Beach, Metropolis Mall, and city center Quick access to all major routes and the highway Boutique-style building with only 8 apartments High-spec technical features including A/C provisions, solar water heater, and photovoltaic system setup.
    Whether for living or investment, this is a rare opportunity in a strategic and desirable location.

    "Biosimilars" ed. by Valderilio Feijó Azevedo, Robert Moots

    Posted By: exLib
    "Biosimilars" ed. by Valderilio Feijó Azevedo, Robert Moots

    "Biosimilars" ed. by Valderilio Feijó Azevedo, Robert Moots
    ITexLi | 2022 | ISBN: 1838819436 9781838819439 1838819355 9781838819354 1839681675 9781839681677 | 91 pages | PDF | 6 MB

    This book discusses biosimilars with chapters on clinical trials, regulation, pharmacovigilance, and the interchangeability of biosimilars with biologics. It addresses future trends in the biosimilars market.

    Introduced in the 1980s, biologic medications have since become important tools in modern medicine. However, biologics are expensive, greatly affecting the healthcare budgets of both underdeveloped and developed countries. Fortunately, biosimilars, which are highly similar, reverse-engineered versions of existing biological medicines and their active ingredients, are now available as more affordable options for patients treated with biologics.

    Contents
    1. Biosimilars - A Regulatory and Clinical Perspective
    2. Biosimilars in Inflammatory Bowel Diseases: General Concepts and Clinical Implications
    3. Rheumatic Diseases and Biosimilars: Evidence about Switch from Originators to Biosimilars in the Real Life
    4. Monoclonal Antibodies for Cancer Treatment
    5. Biosimilar Monoclonal Antibodies in Latin America
    1st true PDF with TOC BookMarkLinks

    More : You find here